|
||||||||||||||||||||||||||||||||||
[發(fā)表評(píng)論] [本類其他產(chǎn)品] [本類其他供應(yīng)商] [收藏] |
銷售商: 上海皓元生物醫(yī)藥科技有限公司 | 查看該公司所有產(chǎn)品 >> |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。
CAS No. : 39809-25-1
MCE 國(guó)際站:Penciclovir
產(chǎn)品活性:Penciclovir (VSA 671) 是一種有效的選擇性抗皰疹病毒 (anti-herpesvirus) 劑,對(duì)于 HSV-1(HFEM),HSV-2(MS) 的 EC50 值分別為 0.5, 0.8 g/ml。Penciclovir 顯示抗皰疹病毒活性且無細(xì)胞毒性。Penciclovir 可防止小鼠死亡。
研究領(lǐng)域:Anti-infection
作用靶點(diǎn):HSV
In Vitro: Penciclovir (0-100 g/ml) shows anti-herpesvirus activity with EC50s of 0.5, 0.8, 2.4, 52, 100, 1.2, 1.6, 0.9, >100 g/ml for HSV-1 (HFEM), HSV-2 (MS), VZV (Ellen), CMV (AD-169), BHV-1 (Oxford 1964), BHV-2 (New York 1), EHV-1(Quai Hals), FHV-1 (B927), SVV, respectively.
Penciclovir (0-100 g/ml) shows no-toxic to uninfected human cells.
In Vivo: Penciclovir (100 mg/kg; s.c.; daily for 5 days) preventes mortality in mouse.
相關(guān)產(chǎn)品:Natural Product-like Compound Library | Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Anti-Infection Compound Library | FDA-Approved Drug Library | Antiviral Compound Library | Drug Repurposing Compound Library | Nucleotide Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | FDA Approved & Pharmacopeial Drug Library | Rare Diseases Drug Library | Human Metabolite Library | Off-patent Drug Library | Highly Selective Inhibitors Library | 2-Deoxy-D-glucose | Brefeldin A | Cytarabine | Dynasore | Imiquimod | Ivermectin | Salubrinal | Ganciclovir | Aphidicolin | Acyclovir | Floxuridine | Ginsenoside Rb1 | Verbascoside | Digitoxin | Trifluridine | Surfactin | Xanthohumol | Theaflavin 3,3'-digallate | Levamisole hydrochloride | ML324 | Guanosine | Pritelivir | Oxytetracycline | Adenosine 5'-monophosphate monohydrate | LDC4297 | Vidarabine | FSL-1 TFA
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球獨(dú)家化合物庫(kù),我們致力于為全球科研客戶提供前沿最全的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動(dòng)劑涉及各熱門信號(hào)通路及疾病領(lǐng)域;
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項(xiàng)目;
• 提供虛擬篩選,離子通道篩選,代謝組學(xué)分析檢測(cè)分析,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項(xiàng)質(zhì)檢報(bào)告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國(guó)客戶實(shí)驗(yàn)驗(yàn)證;
• Nature, Cell, Science 等多種頂級(jí)期刊及制藥專利收錄了MCE客戶的科研成果;
• 專業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,為您提供全球最新的活性化合物;
• 與世界各大制藥公司及知名科研機(jī)構(gòu)建立了長(zhǎng)期的合作。